Related Products
|
||||||
About
EquiReason is an equity research and market-intelligence platform for self-directed investors, independent analysts and research teams. It combines SEC company filings, XBRL financial data, earnings-call transcripts and market information to help users examine financial performance, ownership activity, trends and company exposure. The platform traces market events through economic mechanisms to potentially affected companies and presents each company verdict with supporting and counter-evidence. Research views include financial statements, valuation context, insider and institutional activity, segment revenue data, company-specific measures and alerts, with evidence linked to its underlying source. EquiReason is available through the web and an iPhone app, with a free plan and paid research tiers. It provides research and decision support, not investment advice.
|
About
Intrinsic Alpha is web-based stock research and valuation software for independent investors and analysts. It brings company fundamentals, financial statements, historical growth trends, peer comparisons, stock reports and screening tools into one research workspace. Users can estimate intrinsic value with discounted cash flow models, adjust valuation assumptions and compare scenarios, then organize ideas with watchlists, price alerts and investment-journal notes. The platform also provides company analysis and financial-health information to help users examine a business alongside its market price. A free plan includes limited research and watchlist access; Premium and Unlimited subscriptions add higher or unlimited usage, additional valuation features and expanded watchlists.
|
|||||
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
|||||
Audience
Self-directed stock investors, independent analysts, finance writers and small research teams covering US equities
|
Audience
Independent investors, value investors and stock analysts.
|
|||||
Support
Phone Support
Not Supported
24/7 Live Support
Not Supported
Online
Not Supported
|
Support
Phone Support
Not Supported
24/7 Live Support
Not Supported
Online
Supported
|
|||||
API
Offers API
Supported
|
API
Offers API
Not Supported
|
|||||
Screenshots and VideosNo images available
|
Screenshots and Videos |
|||||
Pricing
$49/month
Free plan available. Analyst is $49/month; Research Pro is $89/month. Annual billing is ten months for twelve. Research Pro has a seven-day trial with no card required.
Free Version
Supported
Free Trial
Supported
|
Pricing
$10/month
Free plan: $0/month, with usage limits. Premium: $10/month, including 15 stock reports per week, five watchlists, and basic DCF models. Unlimited: $15/month, including unlimited stock analyses and watchlists and DCF sensitivity analysis. Annual subscriptions are also offered; Premium is $110/year and Unlimited is $165/year.
Free Version
Supported
Free Trial
Not Supported
|
|||||
Reviews/
|
Reviews/
|
|||||
Training
Documentation
Not Supported
Webinars
Not Supported
Live Online
Not Supported
In Person
Not Supported
|
Training
Documentation
Supported
Webinars
Not Supported
Live Online
Not Supported
In Person
Not Supported
|
|||||
Company InformationEquiReason
Founded: 2026
Turkey
equireason.com
|
Company InformationIntrinsic Alpha
United Kingdom
intrinsicalpha.com
|
|||||
Alternatives |
Alternatives |
|||||
|
|
||||||
Categories |
Categories |
|||||
Integrations
No info available.
|
Integrations
No info available.
|
|||||
|
|
|